tiprankstipranks
Trending News
More News >
BioVaxys Technology (TSE:BIOV)
:BIOV
Canadian Market

BioVaxys Technology (BIOV) Cash flow

Compare
19 Followers

BioVaxys Technology Cash Flow

TSE:BIOV's free cash flow for Q3 2025 was C$-1.06M. For the 2025 fiscal year, TSE:BIOV's free cash flow was decreased by C$-1.86M and operating cash flow was C$-1.06M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -1.86MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Investing Cash Flow
C$ -1.06MC$ 0.00C$ 0.00C$ 0.00C$ 61.36K
Financing Cash Flow
C$ 3.13MC$ 917.10KC$ 1.11MC$ 3.44MC$ 3.35M
End Cash Position
C$ 211.81KC$ 977.00C$ 141.90KC$ 593.12KC$ 2.42M
Free Cash Flow
C$ -2.92MC$ -1.05MC$ -1.57MC$ -5.29MC$ -1.23M
Currency in CAD

BioVaxys Technology Cash Flow